Latest period
$269.10M
YoY change
+3.1%
5Y CAGR
-8.6%
Peak year (2020)
$407.30M
Cumulative CapEx
$3.91B
CapEx history chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: $260.20M
CapEx growth chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: +3.1%
CapEx history table for Edwards Lifesciences (EW) from 1999 to 2025
| 2025 | $260.20M | +3.1% | +$7.80M | ||
| 2024 | $252.40M | -5.2% | −$13.90M | ||
| 2023 | $266.30M | +0.6% | +$1.50M | ||
| 2022 | $264.80M | -19.7% | −$65.00M | ||
| 2021 | $329.80M | -19.0% | −$77.50M | ||
| 2020 | $407.30M | +46.3% | +$128.90M | ||
| 2019 | $278.40M | +15.2% | +$36.70M | ||
| 2018 | $241.70M | +37.7% | +$66.20M | ||
| 2017 | $175.50M | -19.3% | −$41.90M | ||
| 2016 | $217.40M | +104.1% | +$110.90M | ||
| 2015 | $106.50M | +13.7% | +$12.80M | ||
| 2014 | $93.70M | -14.9% | −$16.40M | ||
| 2013 | $110.10M | -13.8% | −$17.60M | ||
| 2012 | $127.70M | +40.9% | +$37.10M | ||
| 2011 | $90.60M | +43.8% | +$27.60M | ||
| 2010 | $63.00M | -1.6% | −$1.00M | ||
| 2009 | $64.00M | -17.9% | −$14.00M | ||
| 2008 | $78.00M | +24.8% | +$15.50M | ||
| 2007 | $62.50M | +5.2% | +$3.10M | ||
| 2006 | $59.40M | +22.5% | +$10.90M | ||
| 2005 | $48.50M | +14.1% | +$6.00M | ||
| 2004 | $42.50M | +12.1% | +$4.60M | ||
| 2003 | $37.90M | -6.9% | −$2.80M | ||
| 2002 | $40.70M | +7.1% | +$2.70M | ||
| 2001 | $38.00M | -17.4% | −$8.00M | ||
| 2000 | $46.00M | +9.5% | +$4.00M | ||
| 1999 | $42.00M | — | — |
- 2025$260.20M+3.1%
- 2024$252.40M-5.2%
- 2023$266.30M+0.6%
- 2022$264.80M-19.7%
- 2021$329.80M-19.0%
- 2020$407.30M+46.3%
- 2019$278.40M+15.2%
- 2018$241.70M+37.7%
- 2017$175.50M-19.3%
- 2016$217.40M+104.1%
- 2015$106.50M+13.7%
- 2014$93.70M-14.9%
- 2013$110.10M-13.8%
- 2012$127.70M+40.9%
- 2011$90.60M+43.8%
- 2010$63.00M-1.6%
- 2009$64.00M-17.9%
- 2008$78.00M+24.8%
- 2007$62.50M+5.2%
- 2006$59.40M+22.5%
- 2005$48.50M+14.1%
- 2004$42.50M+12.1%
- 2003$37.90M-6.9%
- 2002$40.70M+7.1%
- 2001$38.00M-17.4%
- 2000$46.00M+9.5%
- 1999$42.00M—
CapEx values are taken from Edwards Lifesciences's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's current CapEx (TTM) is $269.10M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Edwards Lifesciences (EW) most recent annual CapEx stands at $260.20M (2025) – edged up 3.1% year-over-year.
Edwards Lifesciences CapEx compound annual growth for the 2020–2025 (5 years) window is -8.6%, with a net decline across the window.
Between 2020 and 2025, Edwards Lifesciences CapEx plunged 36.1%, falling from $407.30M to $260.20M.
$407.30M stands as the all-time-high annual CapEx, posted in 2020, against a low of $37.90M during 2003.
Edwards Lifesciences Capital Expenditures by Year
Edwards Lifesciences Capital Expenditures 2025: $260.20M
2025's CapEx for Edwards Lifesciences came in at $260.20M, edged up 3.1% from 2024.
Edwards Lifesciences Capital Expenditures 2024: $252.40M
Edwards Lifesciences posted CapEx of $252.40M in 2024, declined 5.2% below 2023.
Edwards Lifesciences Capital Expenditures 2023: $266.30M
In 2023, Edwards Lifesciences reported CapEx of $266.30M, edged up 0.6% from 2022.
Edwards Lifesciences Capital Expenditures 2022: $264.80M
Edwards Lifesciences CapEx in 2022 was $264.80M, declined 19.7% below 2021.
Edwards Lifesciences Capital Expenditures 2021: $329.80M
Edwards Lifesciences CapEx in 2021 was $329.80M.
See more financial history for Edwards Lifesciences (EW).
Sector peers by CapEx
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation